WELL Health Technologies (TSE:WELL) Sets New 12-Month High on Analyst Upgrade

Shares of WELL Health Technologies Corp. (TSE:WELL) hit a new 52-week high during mid-day trading on Tuesday after Royal Bank of Canada raised their price target on the stock from C$7.00 to C$8.50. The stock traded as high as C$7.30 and last traded at C$7.23, with a volume of 1354392 shares. The stock had previously closed at C$6.95.

Several other analysts also recently weighed in on the stock. TD Securities lifted their target price on shares of WELL Health Technologies from C$8.00 to C$8.50 in a report on Tuesday, December 17th. Scotiabank increased their target price on WELL Health Technologies from C$6.00 to C$7.00 in a research note on Monday, December 16th. Haywood Securities lifted their price target on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th. CIBC increased their price objective on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday, December 13th. Finally, Raymond James boosted their price target on WELL Health Technologies from C$10.00 to C$11.00 in a research note on Tuesday, December 17th.

WELL Health Technologies Trading Down 4.8 %

The firm has a market cap of C$1.72 billion, a P/E ratio of 12.12, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. The business’s 50 day moving average is C$6.04 and its 200-day moving average is C$5.07. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.